Salience Clinical Introduces S2G Framework Pairing AI Screening with Physician-Executive GestaltSubmissions
New methodology provides biopharma and medtech sponsors an auditable path from multimodal clinical data entropy to regulatory-ready narratives. PRINCETON, N.J., United States, 15th Sep 2026 – Salience Clinical, LLC, a clinical development and regulatory advisory consultancy, today announced the launch of the Salience Signal-to-Gestalt (S2G) Framework. The methodology addresses a major industry pain point: clinical…